Skip to main content

Teleflex Incorporated

corporate_fare Company Profile

Teleflex Incorporated

TFX·NYSE·Life Sciences·CIK 0000096943

Teleflex Incorporated is a global provider of medical technology products designed to enhance clinical benefits, improve patient and provider safety, and reduce total procedural costs. The company primarily designs, develops, manufactures, and supplies single-use medical devices. These devices are used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex markets and sells its products to hospitals and healthcare providers worldwide through a combination of its direct sales force and distributors. The company is not dependent upon any single end-market or procedure due to the diverse applications of its products. Major manufacturing operations are located in the Czech Republic, Malaysia, Mexico, and the United States. Teleflex aims for consistent, sustainable, and profitable growth and improved financial performance by increasing market share and operating efficiencies. This is pursued through developing new products and product line extensions, investing in new technologies, expanding product use in existing markets and introducing them into new geographic markets, achieving economies of scale, and expanding its product portfolio via select acquisitions, licensing arrangements, and business partnerships. The company's research and development capabilities, engineering focus, and low-cost manufacturing enable it to bring cost-effective, innovative products to market that improve healthcare safety, efficacy, and quality. Research and development initiatives focus on new therapeutic applications, as well as enhancements and product line extensions for existing products.

Teleflex Incorporated (NYSE:TFX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for TFX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for TFX spans 10-Q, 8-K, 8-K/A.

Recent high-impact activity:

  • Teleflex Q3 Adjusted EPS of $2.63 Crushes $1.90 Consensus
  • Teleflex Q3: Revenue Flat at $567.8M, Gross Margin Jumps to 65.0%, OEM Sale Drives $927.4M Net Income
  • Teleflex Q3 Beats, Lifts 2026 Adjusted EPS Guidance to $7.50-$7.75
  • Teleflex Guides FY Continuing-Ops EPS to $2.84-$3.09
  • Teleflex Locks In $250M Accelerated Buyback with Truist, Backed by OEM Sale Proceeds

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.99B
Net Income
-$905.64M
Diluted EPS
-$20.25
Gross Profit
$1.12B
Operating Income
$118.37M
Cash & Equivalents
$378.56M
Total Debt
$2.64B
Debt / Equity
0.85×
Net Margin
-45.4%
Shares Outstanding
44.62M sh
Source: 10-K · filed 2026-02-27 · accession 0000096943-26-000019

Short Interest & Short Volume

5.87 days to cover

FINRA reported short interest of 4,066,318 shares in TFX as of the October 30, 2026 settlement, a 3.6% decrease from the prior period — about 5.9 days to cover at its recent average daily volume. On November 20, 2026, 79.2% of TFX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,066,318 shares as of October 30, 2026
Change vs prior period▼ 3.6%
Days to cover5.87 at avg daily volume of 692,573
Daily short volume (FINRA facilities)79.2% of 203,877 shares on November 20, 2026
5-day average short volume67.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$161.58
52-week range · as of 2026-11-05 $100.18 – $161.58
Market cap
$6.41B
Volume
655K (0.8× avg)
3-mo avg 839.3K
Live data · 2026-11-21 08:57 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TFX - Latest Insights

TFX
Nov 05, 2026, 2:47 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $150.33
Real-time Price: $161.58 info
Change: +$11.25 (+7%) info
Market Cap: $6.408B info
TFX
Nov 05, 2026, 11:53 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $153.36
Real-time Price: $161.58 info
Change: +$8.22 (+5%) info
Market Cap: $6.408B info
TFX
Nov 05, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $141.31
Real-time Price: $161.58 info
Change: +$20.27 (+14%) info
Market Cap: $6.408B info
TFX
Nov 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $141.31
Real-time Price: $161.58 info
Change: +$20.27 (+14%) info
Market Cap: $6.408B info
TFX
Aug 07, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $134.98
Real-time Price: $161.58 info
Change: +$26.60 (+20%) info
Market Cap: $6.408B info
TFX
Aug 06, 2026, 3:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $138.74
Real-time Price: $161.58 info
Change: +$22.84 (+16%) info
Market Cap: $6.408B info
TFX
Aug 06, 2026, 7:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $136.78
Real-time Price: $161.58 info
Change: +$24.80 (+18%) info
Market Cap: $6.408B info
TFX
Aug 06, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $136.78
Real-time Price: $161.58 info
Change: +$24.80 (+18%) info
Market Cap: $6.408B info
TFX
Aug 06, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $136.78
Real-time Price: $161.58 info
Change: +$24.80 (+18%) info
Market Cap: $6.408B info
TFX
Aug 05, 2026, 4:44 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $136.78
Real-time Price: $161.58 info
Change: +$24.80 (+18%) info
Market Cap: $6.408B info
TFX
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $139.70
Real-time Price: $161.58 info
Change: +$21.88 (+16%) info
Market Cap: $6.408B info
TFX
Jun 15, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $130.09
Real-time Price: $161.58 info
Change: +$31.49 (+24%) info
Market Cap: $6.408B info
TFX
Jun 01, 2026, 6:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $127.57
Real-time Price: $161.58 info
Change: +$34.01 (+27%) info
Market Cap: $6.408B info
TFX
Jun 01, 2026, 6:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $127.57
Real-time Price: $161.58 info
Change: +$34.01 (+27%) info
Market Cap: $6.408B info
TFX
Jun 01, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $128.64
Real-time Price: $161.58 info
Change: +$32.94 (+26%) info
Market Cap: $6.408B info
TFX
Jun 01, 2026, 7:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $128.64
Real-time Price: $161.58 info
Change: +$32.94 (+26%) info
Market Cap: $6.408B info
TFX
May 27, 2026, 5:33 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $130.06
Real-time Price: $161.58 info
Change: +$31.52 (+24%) info
Market Cap: $6.408B info
TFX
May 27, 2026, 5:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $130.06
Real-time Price: $161.58 info
Change: +$31.52 (+24%) info
Market Cap: $6.408B info
TFX
May 07, 2026, 1:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $134.41
Real-time Price: $161.58 info
Change: +$27.17 (+20%) info
Market Cap: $6.408B info
TFX
May 07, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $123.23
Real-time Price: $161.58 info
Change: +$38.35 (+31%) info
Market Cap: $6.408B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets